Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.36M | 5.05M | 4.71M | 4.35M | 3.95M |
| Total Other Revenue | -- | -- | -- | 112.10K | 222.60K |
| Total Revenue | 5.36M | 5.05M | 4.71M | 4.35M | 3.95M |
| Cost of Revenue | 1.46M | 1.52M | 1.58M | 1.27M | 956.20K |
| Gross Profit | 3.90M | 3.53M | 3.13M | 3.07M | 3.00M |
| SG&A Expenses | 9.23M | 9.39M | 9.50M | 9.93M | 10.29M |
| Depreciation & Amortization | 9.30M | 9.09M | 8.82M | 8.46M | 8.06M |
| Other Operating Expenses | 5.26M | 5.09M | 4.88M | 5.13M | 5.35M |
| Total Operating Expenses | 25.25M | 25.08M | 24.79M | 24.79M | 24.64M |
| Operating Income | -19.90M | -20.03M | -20.08M | -20.45M | -20.69M |
| Income Before Tax | -18.47M | -18.67M | -18.79M | -19.20M | -19.50M |
| Income Tax Expenses | 70.20K | 82.60K | 95.10K | 63.90K | 32.40K |
| Earnings from Continuing Operations | -18.54 | -18.76 | -18.89 | -19.27 | -19.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.54M | -18.76M | -18.89M | -19.27M | -19.53M |
| EBIT | -19.90M | -20.03M | -20.08M | -20.45M | -20.69M |
| EBITDA | -15.12M | -14.50M | -13.80M | -14.98M | -16.05M |
| EPS Basic | -0.31 | -0.31 | -0.31 | -0.32 | -0.32 |
| Normalized Basic EPS | -0.19 | -0.19 | -0.19 | -0.20 | -0.20 |
| EPS Diluted | -0.31 | -0.31 | -0.31 | -0.32 | -0.32 |
| Normalized Diluted EPS | -0.19 | -0.19 | -0.19 | -0.20 | -0.20 |
| Average Basic Shares Outstanding | 241.37M | 241.37M | 241.36M | 241.36M | 241.36M |
| Average Diluted Shares Outstanding | 241.37M | 241.37M | 241.36M | 241.36M | 241.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |